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INTRODUCTION
This is the last review of the subject which
may be regarded as reasonably comprehensive
because the body of knowledge in this field
has and is growing so rapidly that complete
coverage of relevant observations is rapidly
approaching book proportions.
Pemphigus and pemphigoid, two chronic
bullous dermatoses, are often difficult to dis-
tinguish clinically. Histologically, the two are
quite different. Pemphigus is characterized by
intra-epidermal bulla formation with acan-
tholysis while pemphigoid is characterized by
subepidermal bulla (1). Until recently the
etiology of each remained an enigma.
Two distinct autoimmune responses have
now been recognized in these two chronic
bullous diseases, both demonstrable by im-
nmnofluorescence. One, an autoantibody to the
intercellular areas of stratified squamous epi-
thelium, is associated with pemphigus while
the other, an autoantibody to the basement
membrane area, is associated with bullous
pemphigoid (2, 3, 9—12). These observations
have served to focus attention on the possible
autoimmune etiology of the two diseases and
on the diagnostic and prognostic value of im-
munofluorescence in differentiating pemphigus
and pemphigoid from other bullous diseases
(3, 11) and from each other.
Past immunologic studies on chronic bullous
diseases were performed with passive agglutina-
tion methods. Wagner et al. (13) have re-
ported agglutination of colloidian particles
coated with extracts of skin as well as other
organs. While sera and blister fluids of
pemphigus patients agglutinated the particles,
the reaction was not specific for pemphigus.
Similarly, Melczer and Vasarhelyi (14) in
agglutination studies with red cells coated with
blister fluids observed positive reactions not
only with sera of pemphigus patients but also
in dermatitis herpetifornñs. Also, studies of
Kano et al. (15), on mixed agglutination on
hep cell cultures revealed reactivity of pem-
phigus sera as well as some control sera.
Comparisons in the latter study with indirect
immunofluorescence staining of intercellular
areas (see below) revealed that the two re-
actions frequently do not concur. Indeed,
absorption of sera with hep cells removed the
reactivity in mixed agglutination but did not
affect the immunofluorescence staining titers.
Thus, it appears that these agglutination
tests reveal non-disease specific antibodies
which are different from those demonstrated
by indirect immunofluorescence.
I. THE ANTIBODY NATURE OF
IMMUNOFLUORESCENT
STAINING
A. Patterns of Indirect Immuno fluorescence
As might be expected, indirect immuno-
fluorescence of skin and other stratified
squamous epithelia with human sera may
yield several different staining patterns. De-
tails of the staining procedures utilized in
such studies have been previously described
(2, 3, 11). Figures 1 to 3 illustrate the stain-
ing patterns obtained with three types of
human autoantibodies. Figure 1 depicts the
staining pattern of antinuclear factor on an
unfixed section of monkey esophagus. Anti-
nuclear factor, .which is associated primarily
with systemic lupus erythematosus, commonly
occurs in a variety of other conditions (3).
Figure 2 depicts the intercellular staining
pattern characteristic of a pemphigus serum
on a comparable section. Thus far, the inter-
cellular staining pattern has been found to
occur only with sera of patients with pemphi-
gust Figure 3 is a photomicrograph of the
indirect immunofluorescent staining of the
* Recent observations indicate that some sera
taken after severe burns may have comparable
reactivity. This problem is currently under investi-
gation. This ciuestion is discussed below in Sec-
tion III-E and IV-A.
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basement membrane area with a serum from
a patient suffering from bulloiis pemphigoid,
again on an unfixed section of monkey
esophagus. This patterii has been found to
occur only with sera of patients \vitIi pern-
phigoid. In the first report on this latter stain-
ing pattern, the disease was also referred to
as a bullous form of dermatitis herpetiformis
(3).
Interestingly, the sites of immunofluorescent
staining observed in pernpliigus and pemphigoid
correspond rather precisely to the sites of the
primary histopathology.
The mere demonstration of indirect staining
patterns such as those illustrated in Figures
1 to 3 is not adequate evidence for the anti-
body nature of the observed reaction. As in
any other phase of immunology, antibodies are
characterized by the sensitivity and specificity
of their reactions in established serologic tests
and by their immuno globulin nature.
Figures 1 to 3 are photomicrographs of indirect
immunofluorescent staining reactions of human
sera with the epitheliuin of unfixed sections of mon-
key esophagus using a conjugate of a rabbit anti-
serum to chromatographically pure human IgG.(For further details on methods see referenees 16
and 17.)
FIG. 1 (Top). Reaction of nuclear antibodies.
Section treated with a 1: 10 dilution of serum of
patient with a "collagen disease". Lumen of eso-
phagus lower left. X 120.
B. Titration of Immunofluorescent
Staining
Some typical reactions with sera of patients
with systemic lupus erythematosus, pemphigus
and bullous pemphigoid respectively are il-
lustrated by the titration shown in Table 1.
These titrations were performed on unfixed
sections of monkey esophagus with a fluorescein
conjugated rabbit antihurnan IgG preparations
with an apparent F/P ratio of 4.5 used at
1/4 unit of arti-IgG/rnl or roughly M mg
antibody protein/mi. (Details of the methods
entailed are given in references 16 and 17.)
Serial dilutions of patient sera were leted
with constant conjugate dilution.
The titrations shown in Table 1, reveal a
sensitivity commensurate with a true antibody
reaction. The details of methodology, par-
ticularly the conjugate characteristics do, of
course, affect the observed sensitivity or titer
of the immunofluorescent staining. Thus, the
careful definition of the system is requisite.
Reports on the use of other mammalian
FIG. 2 (Middle). Reaction of intercellular an—
tihoIies of a pemphigus patient. Section treated
with a 1:10 dilution of serum from a fatal case of
pemphigus vulgaris. Lumen of esophagus lower
left. X 84.
FIG. 3 (Bottom). Reaction of basement mem-
brane antibodies of patient with active bullous
pemphigoid. Serum diluted 1:10. Lumen of esopha-
gus upper left. x 210.
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TABLE 1
Some typical titration of vera containing different tiue autoantibodie. on ection
of monkey eophagu by indirect immunoftuorescence*
Sera tested
Titers Negative Nuc—320 IC—640 BM—640
* See text for description of methods of indirect immunofluorescence. Staining reactions: Nuc =
antinuclear factor (see Figure 1); IC = intercellular antibodies (see Figure 2); BM = basement mem-
brane antibodies (see Figure 3).
epithelia, notably guinea pig lip sections (10),
suggest that these may be used in place of
primate tissue. While this is frequently true,
exceptions do occur (8). While fresh, frozen
monkey esophagus less than one week old,
appears at the moment to be the most re-
liable tissue, such tissue is not generally
available. Thus, guinea pg lip or some other
tissue will have to be adopted as a standard
test antigen. (Details of optimal test pro-
cedures for pemphigus and pemphigoid anti-
bodies will be reported in the near future.)
Under carefully controlled conditions, such
titrations as are shown in Table 1, are quite
as reproducible as any other well defined
serologic test method. This was borne out by
a recent double blind study on Brazilian
pemphigus foliaceus (8). Of 30 sera tested in
two laboratories, 12 yielded identical titers,
16 one dilution difference, 1 two dilution
difference and 1 variable results (no reaction
to titers of 1:160) in one laboratory and no
reaction in the other laboratory. The latter se-
rum was found to contain an inhibitor. This
observation, in turn, now has opened a new
area of study.
C. Methods of Quantitative Analysis of
Immuno fluorescent Staining
The selection of optimal conditions for test-
ing of patient sera is based on chessboard
titration with different antigens, sera and
conjugates. These chessboard titrations are
performed by testing serial dilutions of a given
conjugate. Figure 4 illustrates the results of
such a chessboard titration on guinea pig oral
mucosa.
As indicated in Figure 4, constant titers of
patient sera are obtained from 2 units/ml down
to 1/ia units/ml of conjugate. (One unit is
roughly equal to '/oi. mg antibody protein/ml.)
This is referred to as the plateau titer of a
patient serum. The conjugate end point in
such a titration (i.e. the highest dilution of
conjugate that still gives a plateau titer with
the serum) is referred to as the plateau end
point.
The staining properties of conjugates depend
on their optical and immunologic sensitivity
ratios. Optical sensitivity ratios are expressed
as ratios of fluorescein to protein while im-
munologic sensitivity ratios are expressed in
terms of antibody to protein ratios (in these
Nuc* Ic*
Normal S.L.E. Pemphigus Pemphigoid
BM* IC
Dilutions tested
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Plateau end point
(of conjugate*)
Plateau titer
(of serum A**)
21 1 ! !_! _! _i_J.
2 4 8 16 32 64 128
Units/mi of Conjugate
* The characteristics of this conjugate are given with the followin Table 3.
** Serum A as listed in Table 3.
n in expression 10 2n
Fiu. : Chessboaid titration with a serum containing basement membrane antibodies on
guinea pig oral mucosa.
studies as units/1% protein). These two
conjugate characteristics together with their
staining properties at different 'use dilutions"
as seen in chessboard titrations serve to define
the staining properties of conjugates and
afford a basis for quantitative analyses of
immunofluorescent staining. Section IV B sum-
marizes the recommended conditions for demon-
strating these antibodies.
D. Organ. Specificity Studies
The organ specificity of the indirect im-
munofluorescent staining of intercellular areas
of epithelia with pemphigus sera and the
basement membrane area with sera from pa-
tients with bullous pemphigoid is summarized
in Table 2.
As indicated in Table 2, the intercellular
antigen reactive with antibodies of pemphigus
occurs in all stratified squamous epithelia but
not in 35 other tissues tested (3). On the
other hand, the basement membrane antigen
reactive with the antibodies of bullous pem-
phigoid occurs not only beneath all stratified
squamous epithelia but also in the urethra,
bladder, trachea, bronchi and gall bladder but
not in the 30 other tissues treated. These ob-
servations afford a qualitative indication of the
specificity of the two types of antibodies.
Some recent quantitative analyses by Dr.
Georg Wick (unpublished) point to signifi-
Serum
titers
(n) ***
5120(9)
2 560(8)
1280(7)
640(6)
320(5)
160(4)
80(3)
40(2)
20(1)
10(0)
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cant quantitative differences in the reactivity
of basement membrane autoantibo dies in dif-
ferent tissues. Aialyses were performed by
chessboard titrations of indirect immuno-
fluorescence. Figure 4 is an example of these.
The following Table 3 summarizes results of
16 chessboards of this type.
Significant differences in titers of basement
membrane antibodies of sera A and B did ap-
pear on different tissues. Titers of serum A
ranged from a lower limit of 160 on monkey
oral mucosa hair follicle and skin to an upper
limit of 10,240 on guinea pig hair follicle root
sheath (a difference of 26). Similarly,
titers of serum B ranged from 10 on monkey
skin to 320 on monkey esophagus (a difference
of 2). Quantitative differences in plateau end
points of conjugate are also apparent. With
serum B on monkey tissues, plateau end points
ranged from ½ to ¼ units/nil, while the re-
maining chessboard titrations yielded plateau
TABLE 2
Organ specificity of intercellular substance and of
basement membrane antibodies
Indirect
immunofluorescence
reactivity of antibodies
Tissues tested
Skin + +
Lip and nasal mucosa + +
Gingiva, tongue + +
Soft palate, uvula + +
Vagina, penis + +
Esophagus + +
Cornea of eye + +
Anus
Gall bladder
+ +
— +
Bladder, urethra — +
Trachea, bronchi — +
30 other tissues*
* 30 Other tissues tested (all negative) include:
stomach, duodenum, liver, large intestine, rectum,
kidney, pancreas, submaxillary, thyroid, prostate,
seminal vesicle, uterus, fallopian tube, breast,
sweat gland, pituitary, adrenals, ovary, testes,
ilium, ornentum, spleen, thymus, heart, aorta,
brain, blood smears, sclera (eye), skeletal muscle,
and smooth muscle.
end points of '/i or 1/32 units/mI. Since all
factors but antigen source remain constant,
and since such findings appear to be repro-
ducible, these variations in plateau titers of
two sera and in plateau end points of the
one conjugate point to quantitative and/or
qualitiative differences in the basement mem-
brane antigen in different tissues.
Similar quantitative analyses of "pemphigus"
antibodies also reveal significant differences h
reactivity of the intercellular area in different
epithelia.
E. Summary of Evidence for Antibody
Nature of "Pemphiqus" and
"Pemphigoid" Antibodies
The IgG iature of the intercellular anti-
bodies of pemphigus and the basement mem-
brane antibodies of bulious pemphigoid is
thdicated by the fact that the fluorescein
labelled antiglobulins used in their demon-
stration are prepared by immunizing rabbits
with chromatographically pure IgG and yield
only a single line of precipitation in the IgG
region in immunoelectrophoretic tests against
normal human serum. While the conjugates
were not absorbed to remove L (A) chain
antibodies, tests of some selected high titer sera
with conjugated antihuman IgA and 1gM (18)
reveal either no reactivity or low titers.
On the basis of the evidence summarized in
Table 1 (relating to sensitivity), Tables 2 &
3 (on specificity) and in the preceding para-
graph on the immunoglobulin nature of the
reactants, we may regard the indirect immuno-
fluorescent staining of intercellular areas of
epithelia with pemphigus sera and the staining
________
of basement membrane areas with sera of
patients with bullous pemphigoid as reactions
of true antibodies. (See definition of antibody
in first paragraph of this section.) Some im-
munologists deem it desirable to demonstrate
reactions of antibodies by more than one
serologic method. Thus far, the two above
mentioned reactions have been demonstrated
by indirect (2—11) and mixed immuno-
fluorescence (10). In addition, other serologic
methods, although not totally convinchg to
date, are currently being employed to study the
pemphigus and pemphigoid reactions. These
methods will be alluded to in section VA.
Inter-
cellular
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TABLE 3
Quantitative differences in reactivity of basement membrane antigen of different epithelia
as revealed by chessboard titrations
System: Antigens—unfixed sections of tissues as listed
Sera: A and B of Bullous Pemphigoid Patients (controls not listed)
Conjugate: apparent molar F/P = 4.8; 16 units/1% P
Standard staining system and optics
Observation: Unpublished data of Dr. Georg Wick
Tissue Species
Plateau endpoint' in units/ml* Plateau titers as nf (and as titers)
Serum A Serum B Serum A Serum B
Esophagus
Oral mucosa
Hair follicle root
sheath
Skin
Monkey
Monkey
Monkey
Monkey
3
32
'32
3
6—7
(640—1280)
4—5
4—5
(160—320)
4—5
(160—320)
4-5
(160—320)
3—4
)
2
(40)
0io
Esophagus
Oral mucosa
Hair follicle root
sheath
Skin
Guinea pig
Guinea pig
Guinea pig
Guinea pig
T2
3j'
3I6
z
32
H6
6
(640)
9
(5120)
9—10
(5120-10,240)
8—9
(2560—5120)
2-3
(40-80)
3—4
(80—160)
3-4
(80—160)
3.4
(80—160)
* Plateau endpoints of conjugate giveil in units/ml: 1 unit/ml or 34 mg antibody protein/mi. Plateau
endpoints afford an approximate measure of the concentration of reactive antigen (error 1 doubling
dilution).
t Plateau titers are expressed here as exponents, n, in the expression: Titer = 10 X 2' Plateau titers
are a measure of antibody concentrations in antisera (error 1 doubling dilution or n 1).
II. AUTOANTIBODY NATURE OP SKIN
ANTIBODIES AND THEIR IN VIVO
REACTIVITY (2—4, 11, 19—25)
A. The Autoantibody Nature of the Intercellular
Antibodies of Pernphiqus (3) and the Base-
ment Membrane Antibodies of Bullous Pem-
phigoid
These have been demonstrated to be auto-
antibodies by performing indirect staining re-
actions with patient sera on sections of their
own skin biopsies (3, 11). Some technical diffi-
culties arose in these tests due to the in vivo
binding of IgG at the antibody combining site.
That is, sections of skin biopsies of patients
with pemphigus when treated with fluorescein
labelled anti-IgG alone yield staining of the
intercellular areas comparable to that seen in
the indirect staining method, e.g., as in Figure
2. Obviously, on such sections, it is not possible
to demonstrate the autoantibody nature of the
patient's skin antibody. Only in some areas of
some patients' skin biopsies where minimal in
vivo bound IgG appeared could the auto-
antibody nature of that patient's intercellular
aitibodies be demonstrated (3). Much the
same was true in the demonstration of the
autoantibody nature of basement zone anti-
bodies (11). The capacity of both the inter-
cellular and the basement zone antibodies to
bind in vito has been demonstrated by intra-
derinal injection of monkeys with antibody con-
taining sera and the subsequent examination of
biopsies of the injected sites for bound anti-
body (3, 18). Here we refer to the in vivo
binding of antibody rather than IgG because
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TABLE 4
sSumrnary of reported* incidence of intercellular and
basement membrane autoantibodies as demon-
strated by indirect imrnunofiuorescnce
Pemphigus
Bullous pemphigoid
Dermatitis herpeti-
formis
Other bullous diseases
Allergies
Other skin diseases
SLA, RA, other col-
lagen dis.
Other diseases
Normals
Totals 785 118 31 636
* Findings reported in references 2—8 and 10-42;
and 29 ref. 6, the "105 patients with various skin
diseases and healthy persons—" were estimated to
include 15 normals. The tests reported were per-
formed on sections of human skin, monkey, rabbit
and guinea pig esophagus.
t Titers of 10 or greater are included as positive
though the titers of 10 were listed as "doubtful"
in some of the reports. Negative reactions mean
no reactivity at a 1:10 dilution of serum.
t This includes pemphigus vulgaris, p. foliaceus,
p. erythematosus, and p. vegetans.
specificity controls can be carried out in such
studies.
B. In Vivo Binding of IgG and Complement
Recent studies have revealed not only the in
vivo binding of IgG but also of complement to
the intercellular areas of patients' skin biopsies
(19, 20). Interestingly, it has also been pos-
sible to demonstrate the in vivo fixation of
complement in skin biopsies of patients with
fogo selvagem (21). Preliminary observations
also point to a depression of serum complement
levels in active pemphigus (22). Complement
fixation in vivo occurs also in bullous pem-
phigoid in the basement membrane zone (41)
but the serum complement levels in this con-
dition remain to be determined. To date, it has
not been possible to demonstrate in vitro fixa-
tion of complement in either system (19).
Evidence suggesting that the IgG bound in
vivo to the intercellular areas of skin biopsies
of pemphigus patients is, indeed, in vivo
bound autoantibody may be summarized as
follows: (1) autoantibodies reactive with the
site of fixation are present in patient's sera;
(2) these antibodies can bind in vivo when in-
jected into monkey skin; (3) complement is
also fixed to the intercellular areas. On the
strength of these observations, it seems rea-
sonable to assume that the IgG fixed to the
intercellular areas of the epidermis in pem—
69 phigus is, indeed, in vivo bound autoantibody.
34 These three observations also hold true for the
255 basement membrane antibodies of bullous pem-
60 phigoid. While in vivo binding of IgG to the
78 basement membrane also occurs in lupus
44 erythematosus the pattern of fluorescence isdifferent; i.e. in LE the band of staining is
wide in contrast to the narrow band in the
basement membrane area seen in skin bi-
opsies of patients with bullous pemphigoid.
Burnharn et at. (23), using direct immuno-
fluorescent staining, observed basement zone
localization of IgG in skin biopsies of systemic
lupus erythematosus patients. Cormane (24),
and more recently, Tan and Kunkel (25), have
confirmed Burnham's observations and de-
scribed similar staining patterns in discoid
lupus erythernatosus. Unlike bullous pemphi-
goid, however, circulating basement membrane
antibodies have not been detected in sera of
S.L.E. and D.L.E. patients (11).
Observations on such in vivo localization of
iinmunoglobulins in pemphigus erythematosus
will be considered shortly in connection with
the association of chronic bullous diseases with
other immunologic disturbances.
III. SURVEYS OF INCIDENCE OF "PEMPHIQU5"
AND BASEMENT MEMBRANE ANTIBODIES
A. Concurrence of Skin Autoantibodjes and
Chronic Buttous Diseases
The following Table 4 smnmarizes results of
indirect immunofluorescent staining of inter-
cellular areas and basement membrane areas as
reported in 10 publications that have appeared
on the subject to date (2—8, 10—12).
It appears from the summary of reported
data shown in Table 4 that the intercellular
antibodies have only been found in pemphigus
Diagnoses
Inter-
cellular
118
"Skin" antibodies
reportedt
Base-
ment Neg-item- ativef
brane
32
31 20
44
No. of
cases
150
51
44
69
34
255
60
78
44
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sera while the basement membrane antibodies
have only been demonstrated in bullous pem-
phigoid séra.
Since the data listed in Table 4 were re-
ported, one of us (T.C.), has tested over 1100
additional controls in "blind" studies on sera
sent from other clinics without encountering a
clear cut "false positive". (These observations
have been reported in abstract form at the same
meeting as ref. 40.) Another report now in
preparation (29), however, points to the ex-
istence of problem cases in association with
myasthenia gravis. This would, by some cri-
teria, be deemed as "false positive". Also, some
burn sera appear to stain the intercellular areas
of some stratified squamous epithelia. Both of
these observations are considered in section B
below. (They are excluded from Table 4 be-
cause it is felt that the relation of these cases
to pemphigus remains to be clarified.)
B. Bct.sement Membrane Antibodies and
Bull ous Pemphigoid
It is also evident from the data in Table 4
that most but not all patients with bullous
pemphigoid have basement membrane anti-
bodies. More detailed studies of this system re-
vealed that all patients with active bullous
pemphigoid lesions had basement membrane
antibodies while most cases with no such anti-
bodies had no active lesions. These relation-
ships which are reported in three publications
to date (11, 12, 29) are summarized in Table
5.
Interestingly, skin biopsies of one of the pa-
tients with lesions and no circulating anti-
bodies (one of the cases included in Table 5)
yielded positive staining for in vivo bound IgG
on the basement membrane. It will be neces-
sary to gather data on the frequency of this
combination of observation before its signifi-
cance can be assessed.
C. Titers of Antibodies to Intercellular Areas
and Severity of Pemphiqus
Several studies have revealed that there is a
direct relationship between severity of pemphi-
gus and the titer of intercellular antibodies (3,
5, 6, 8, 10). The observations reported in five
publications on non-endemic pemphigus (3, 5,
6, 10, 29) are summarized in the following Table
6. Non-endemic pemphigus as defined here in-
TABLE 5
Summary of reports* on relation of presence of
basement membrane antibodies to disease activity
of bullous pemphigoid
Disease
activity
Immunofluorescent
staining of basement
membrane Totals
Positivet Negative
Active 31 8 39
Inactive 12 12
Totals 31 20 51 cases
TABLE 6
Summary of reports* on relation of titers of
intercellular antibodies to extent of
pemphigus lesions
Extent of
Titers of 'pemphigus"
antibodies
lesions of
pemphigus
Totals
100 30—60 10 Neg.
Extensive 25 4 29
Moderate 4 12 4 it 21
Slight 1 5 6 5 17
None 2 5 21 28
Totals 30 23 15 27 95 cases
* Findings reported in references 3, 5, 6 and 10
and 29. For ref. 3, "Few lesions" was equated to
slight. For ref. 10, "Few moderate" was equated
to moderate. Information on 6 cases was ab-
stracted from the text of ref. 6. Cases in ref. 10
with titers of 90 are included in this table with
cases having titers of 100; sera from this group
that were subsequently retested on primate tissue
did yield high titers.
t This case is still under investigation (29).
Other cases in this series (29) with titers of 20
or 40 are grouped here with those having titers
of 30—40.
cludes pemphigus vulgaris, pemphigus vegetans,
pemphigus erythematosus and pemphigus foli-
aceus, except the endemic
selvagem).
As is evident from the summary shown in Ta-
ble 6, the titers of intercellular antibodies is
usually 100 or more in most of the severe cases;
these titers range up to a maximum of 2560.
* Findings reported in references Ii, 12 and 29.
t As for Table 4.
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Most negative sera came from patients with 110
active lesions. Obviously, carefully standard-
ized and controlled test procedures are requisite
for such studies. However, the resultant corre-
lation between titer and severity is quite a strik-
ing one. Of eveH greater import is the fact that
titers of intercellular antibodies of individual
patients fluctuate with changes in condition (5,
6,81.
D. Brazilian Pernphigu8 Foliaceus (BPF)
Because of its endemic nature and high in-
cidence in endemic foci, BPF or fogo selvagem
constitutes a significant public health problem
in south central Brazil. It is estimated that
there are approximately 1000 cases per year in
the endemic areas of South America.
Clinically and histologically, BPF is indis-
tinguishable from non—endemic pemplHgus foli—
aceus. Numerous observations, however, point
to an arthropod borne infectious agent as an
etiologic factor in the disease (27): 1) BPF
is only known to occur in South America; 2)
within the endemic areas, most autochthonous
cases occur in well defined foci; 3) one such
focus in which over 400 cases have appeared
in the last 25 years arose in the Belo Horizonte
area after the hospitalization of one patient
with fogo selvagem from another endemic area
in a local hospital (28) 41 all racial and eco-
nomic groups in endemic foci appear to be
TABLE 7
Relation of titers of intercellular antibodies to
severity of Brazilian pcinphigus foliaeeus* (BPF)
Severity of BPF
Titers of intercellular antibodies
Totals
2560 184%_ 32 80—10 Meg.
Deteriorating 2 2
Stationary 3 lit 14
Improving 3 5 2 10
Remission 1 1 2
Totals 8 16 2 1 1 28
* Reported in ref. 8.
t One patient whose serum yielded a variable
titer on the initial double blind test; three other
sera on this patient on later tests yield titers of
2560, 640 and 640. Thus this case is listed as having
a titer of 640 in this table.
afflicted; 5) about 10% of the BPF patients
have relatives living in the same household
who have or have had the same disease. Rela-
tives living outside the endemic area are not
so affected; 6) some Brazilians living in en-
demic foci regard a black fly commonly called
"Burashubu" (genus Eusimulidia) as being the
vector of the disease.
Immunofluorescent studies of sera from pa-
tients with fogo selvagem (8) revealed the
presence of intercellular antibodies histologi-
cally indistinguishable from those associated
with pemphigus vulgaris and other forms of
non-endemic pemphigus (see Figure 2). How-
ever, the titers of the intercellular antibodies
appear to be significantly higher in BPF than
in non-endemic pemphigus. The following Table
7 summarizes the relationship between titers of
intercellular antibodies aHd the severity of fogo
s1vagem in 28 cases examined in a double
blind study.
As in cases of non-endemic pemphigus (see
Table 5), the severity of BPF appears to be
related to the titer of intercellular antibodies.
This correlation was obtained in a double blind
study. The reason for the relatively higher
titers in BPF (Table 7 vs. Table 6) remains to
be determined.
The present state of knowledge about Bra-
zilian pemphigus foliaceus (BPF) or fogo
selvagem may be summarized as follows: 1)
the distinctive epidemiology of BPF is strongly
suggestive of an arthropod borne infectious
agent; 2) clinically and histologically BPF is
indistinguishable from the iion-endemic form of
pemphigus foliaceus; 3) in both forms of the
disease, the patient's sera eontaiii antibodies to
a component of the intercellular areas ot
stratified squamous epitheliiim and the titers
of these antibodies appear to be a function of
the disease activity, though titers in BPF are
higher.
One hypothesis which reconciles these ob-
servations is that a causative microorganism
of BPF shares antigenic determinants with
stratified squamous epitheliunt The infected
host would develop antibodies to this common
antigemc determinant. These autoantibodies in
turn could produce the observed disease proc-
ess. Obviously, other hypotheses may be formu-
lated to reconcile the observations on hand.
However, until more facts become available all
hypotheses must be regarded as science fiction.
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E. Association of Pemphigus and Pemphigoid
with Other Immunologic Disturbances
Current studies on the association of pem-
pingus with myasthenia gravis indicate that the
two diseases concur more frequently than
would be expected by chance (7, 29). At pres-
ent, six cases with both diseases are under
study. Associations of the two diseases had been
reported previously (30), as has the association
of pemphigus with a thymoma and LE cell
phenomenon (31). In one case now under
study (7), the patient was found to have not
only pemphigus erythematosus and myasthenia
gravis, but also a thyrnoma. The patient's
serum was found to contain not only the in-
terccllular antibodies of pemphigus and the
muscle striation antibodies of myasthenia gravis
but also nuclear antibodies. These latter reac-
tions are illustrated in Figures 5 and 6. The
exacerbation of the pemphigus erythernatosus
in this one case was apparently triggered by
exposure to sunlight. At the time of the re-
lapse, the patient developed a bufferily rash
resembling that associated with L.E. This is of
particular interest since it has been well es-
tablished that ultra light cai induce acaithol-
ysis in patients with pemphigus (32).
lVlore recent studies of Chorzelski (33) sug-
gest that pemphigus erythernatosus indeed may
represent a combination of pemphigus erythe-
matosus and lupus erythematosus. TThpublished
observations of this group reveal not only the
presence of antinuclear antibodies in combina-
tion with pemphigus antibodies in most of these
patients but also the presence of in vivo bound
IgG in the basement membrane area. (See dis-
cussions of in vivo reactions above for interpre-
tation of this latter observation.) These obser-
vations raise the spector of the perennial debate
about the relationship of lupus erythematosus
to pemphigus erythematosus (34, 35)
Such relationships have not been as well de-
termined for bullous pemphigoid, although the
authors are currently studying 3 cases of bul-
bs pemphigoid with systemic lupus erythe-
matosus (36). Two of these patients have two
types of antibodies; basement membrane anti-
bodies associated with bullous pemphigoid, and
antinuclear antibodies associated with S.L.E.
F. "Pemphiqus" Antibodies in Problem Cases
Two reports that are presently in prepara-
tion merit mention here. One relates to skin dis-
eases which probably represent pemphigus
Fia. 5. A negative immunofluorescent staining reaction on a skeletal muscle section with
a 1:20 dilution of a control serum. The line of nonspecific staining in the lower left is due
to the staining of monkey gamma globulin in the interfiber space. >< 600.
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FIG. 6. Staining of eross-striations and some nuclei with a 1:20 dilution of serum J. C. by
indirect immunofluorescence. X 600.
vulgaris. In such situations the disease may be
characterized by a triad of signs: a) bullous or
nonbullous skin lesions of various types with
no acantholysis Ii) "pemphigus" antibodies at
significant titers (40 or more under standard
test conditions) and c) response to corti-
costeroids. Two cases of this type are now being
reported by Peck, Ossermai et al. Both suffered
from concurrent myasthenia gravis. (Further
details on concurrent pemphigus and myas-
thenia gravis appear above.) In one of these
cases, bullous lesions had been diagnosed as
"drug eruption." Pemphigus antibodies had
been observed over a period of three years.
Numerous skin biopsies over this period were
negative for acantholysis. However, at the end
of three years, the typical histopathology of
pemphigus did develop. The second case of
this type still has not developed acantholytic
lesions; on the basis of the experience with
the first case, however, the second is referred
to as true pemphigus.
The IgA and 1gM "Pemphigus" and "pem-
phigoid" antibodies associated with the re-
spective clinical conditions should at this point
be regarded as problematic. While IF staining
with monospecific anti IgA and 1gM conjugates
has been observed (R. E. Cormane also B.
Pernis, personal communications) the titers of
such reactions had not been reported. Work
now being completed in this laboratory (37)
indicates that in at least some cases titers with
anti IgA conjugates are adequate to qualify the
observed staining reactions as those of anti-
bodies. (See Section I of this review for defini-
lions and explanations.)
Thivolet and Beyvin (50) called the atten-
tion to the resemblance of immunofluorescent
staining reactions with certain post burn sera
to those of pemphigus antibodies. A report
now being prepared by F. Milgrom, Kano et al.
confirms and extends these observations on the
occurrence of "pemphigus like" antibodies in
association with the so called post burn syn-
drome. One of the unanswered questions in
this area of study is whether this post burn
syndrome is indeed a form of "atypical pem-
phigus."
iv. POSSIBLE SOURCES OF ERROR AND THEIR
FUTURE RESOLUTION BY OTHER
SEROLOGIC METHODS
A. Blood Grovp Antibodies
Szulman (38), and more recently, Grob and
Inderbitzen (39) have demonstrated inter-
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cellular staining patterns on esophageal mu-
eosa, similar to those observed with pemphigus
sera using strong anti-A and anti-B blood group
sera. Although similar staining patterns do oc-
cur, it appears that the basic reactions are dif-
ferent. Grob and Inderbitzen (39) were unable
to inhibit the intercellular staining pattern of
pemplugus sera by pre-absorption with AB sub-
stance. But, such pre-absorption of the anti-
A and anti-B sera with AB substance removed
their positive staining patterns. This clearly
indicates that the pemphigus antigen is im-
munologically distinct from the blood group A
and B substance. The latter observation has
been confirmed in unpublished studies by Dr.
Ablin in the laboratory of one of the writers
(E.H.B.)
This apparent histologic identity of immuno-
fluorescent staining patterns of blood group
antibodies and pemphigus antibodies affords a
striking example of one of the axioms of im-
munohistology, namely, that the demonstration
of apparent identity of histologic localization
cannot be interpreted as a demonstration of
antigenic or biochemical identity of the struc-
tures stained.
Several other examples of such divergence
between histologic identity and non-identity of
the reactive structure have already been docu-
mented. It may be the "pemphigus like" anti-
bodies associated with some burn sera (see
Section Ill-F above) may also fall in this
category. For example, absorption of positive
burn sera with red cells of appropriate blood
groups has, thus far, failed to diminish the
titer of their immunofluorescent staining of the
intercellular area of the epithelia tested; while
it appears from these observations that the
staining reaction of burn sera are not due to
blood group antibodies, this does not preclude
the possibility that they may be due to still
another antigen antibody system, thus, the use
of the expression, "pemphigus like" antibodies.
B. Cytoplasmic Staining Reactions and
Nonspecific Staining (NSS)
Another possible source of "false positive"
reactions is the cytoplasmic immunofluorescence
staining of certain stratified squamous epi-
thelia obtained with some human sera. Such
staining reactions have been reported in refer-
ence 10, 29 and elsewhere. Thus far, such
staining reactions have not yet fulfilled the
criteria of antibody reactions as developed and
defined in section I. In the writers' experience,
such cvtoplasmic staining reactions, though
rnorphologicallv distinct, have been confused
with pemphigus antibodies by some investi-
gators.
Another potential source of "false positives"
is the NSS due to the incorrect use of con-
jugates. Careful quantitative selection of proper
optical and immunologic sensitivity ratios and
fluorescein concentration in the conjugate dilu-
tions used is essential for reproducible results
(16, 17). (See Section I-E for further details.)
Otherwise, confusion may arise between specific
staining of "pempliigus" antibodies with what
appears to be the non-immunologic adherence of
immunoglobulins of normal sen. Such nonspecific
staining is due to the use of excessive con-
centrations of conjugates or the use of "over
conjugated" conjugate. Specifically, antihurnan
IgG conjugates must be adjusted to % unit/
ml of antiglobulin and should have an ap-
parent molar fluorescein to protein ratio of
about 4 or less. Conditions other than these
call for "interpolation" of experienced in-
vestigators. Non-specific staining reactions with
some normal control sera are also encountered
occasionally. These distinguish themselves from
the immunofluorescence staining of sera from
active cases of pemphigus by their dull green
appearance in contrast to the bright apple
green staining of intercellular areas that appear
with "pemphigus" antibodies. Such nonspecific
staining of intercellular areas with normal sera
is probably due to the non-immunologic ad-
herence of "normal" IgG. This is a common
problem in immunofluorescence staining, par-
ticularly, with low dilutions of sera. Table S
summarizes the recommended conditions for
demonstrating "pemphigus" and pemphigoid
antibodies.
C. Conclusions Relating to Possible Sources
of Error
Experiences to date, in at least 10 labora-
tories (see 2, 4, 5, 8, 9, 10, 19, 20, 29, 39) by
at least 30 investigators, reveal that pemphigus
antibodies are essentially disease specific (with
the possible exceptions listed in section III-
E). However, as is evident from the two pre-
ceding sections, blood group antibodies, some
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TABLE 8
Recommended conditions for indirect (labeled
antiglobulin) immunofluorescent demon-
stration of "pemphigus" and
"pemphigoid antibodies*
Antigen
Unfixed; 4 ,z sections of guinea pig lips (mu-
cosa); or monkey esophagus fresh frozen
and stored less than 7 days.
Sera
Uninactivated; initial dilution 1:10 or 1:20
serial 2 fold dilutions to endpoint.
Conjugate
Optical sensitivity or F/P (fluorescein to
protein) ratio: crude globulin molar F/P =
4 to 5; weight F/P = 10.6 to 14.0 or IgG
or antibody molar F/P = 2.7 to 3.0; weight
F/P = 7.2 to 8.0
Immunologic sensitivity or Ab/P (antibody
to protein) ratio Ab/P = 1 mg/1% = 0.1 or
more; Ab nitrogen/1% P = 160 mcg/1% P
or more or approximately 4 units/1% or
more
Dilution used for staining should contain
less than 4 meg fluorescein/ml; but 20 to
30 mcg Ab/ml or approximately 3fi unit/mi.
Technique
Sera 30'; Wash 30'; Conjugate 30'; Wash 120'.
Optical sy.siem
Hg vapor light (Osrarn HBO-200)
11.0. 1 or U.G. 5 (Schott) or comparable
excitor filter cardioid (reflecting type)
darkfleld condensor
* References 17 and 58 afford some background
information for this table. Further details and
rationale of section of optimal conditions will be
reported in a book entitled "Autoimmunity in
Pemphigus and Pemphigoid".
cytoplasmic staining reactions and certain
types of non-specific staining do constitute
possible pitfalls in the demonstration of these
pemphigus antibodies. As indicated above,
other as yet unrecognized pitfalls may be en-
countered in the future.
In so far as the immunofluorescent demon-
stration of "pemphigus" antibodies is con-
cerned, it is necessary, at present, to consider
all observed reactions carefully and critically
with due consideration of the recognized
sources of possible confusion. It seems rea-
sonable to hope that functional, reliable and
quantitatively defined methods to aid in the
further differentiation between "pemphigus"
antibodies and such irrelevant factors as those
considered in this and the preceding para-
graphs will become available in the not-too-
far-distant future. Other serologic methods
hold out the greatest hope in this direction.
D. Other Serologic Methods
As indicated in Section I, we may consider
as part of the definition of antibodies, their
demonstration by more than one serologic
method. Thus far, mixed immunofluorescence
(10) is the only other reported method for the
demonstration of "pemphigus" antibodies.
However, unpublished studies (39) have served
to demonstrate these antibodies by direct im-
munofluorescence with labeled patient sera
and with radiographic methods. Pemphigus
antibodies have also been demonstrated in in-
tercellular areas by electron microscopy with
the ferritin labelling method (40). When we
consider these various other methods (i.e.,
mixed and direct immunofluorescence, ferratin
labelling and radioautography) it becomes ap-
parent that these are only "variations of the
theme" of indirect immunofluorescence.
Efforts to achieve in vitro complement fixa-
tion either with the classic hemolytic system or
by immunofluorescent demonstration of com-
plement fixation with patient sera have been
uniformly negative thus far (19,41).
Precipitation reactions with ethanol soluble
fractions (to be discussed in a subsequent sec-
tion) are currently under study but the rele-
vance of these remains to be determined (Fed.
Proc., 1968) (42, 43). The same may be said
for passive hemagglutination reactions with
this ethanol soluble fraction. Studies on ex-
perimentally produced antisera now afford a
further stimulus to tile persual of these studies.
v. EXPERIMENTAL PEMPHIGUS
Grob and Inderbitzen (45), working in
Lever's Laboratory have reported on the iso-
lation of an "insoluble" fraction from rabbit
esophagus mucosa which specifically absorbed
out the immunofluorescent staining activity
from pemphigus. Trypsin treatment of this "in-
soluble" fraction abolished the absorbing ac-
tivity. This antigen when injected into rabbits
over prolonged periods of time (at least 2
months) elicited the production of antibodies
which gave indirect immunofluorescent pat-
terns indistinguishable from those obtained with
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pemphigus sera. Tnderbitzen and Grob (46)
further report on the experimental production
of acantholytic lesions in sensitized rabbits with
high titers of anti-epithelial (intercellular) anti-
bodies using dry ice. Typical acantholytic le-
sions were noted in about 24 hours.
On the other hand, Ablin and Beutner (47)
demonstrated by absorption studies with frac-
tions of bovine esophageal mucosa and pern-
phigus sera that both the insoluble fraction
and an "ethanol soluble" fraction could re-
move the capacity for specific staining of the
intercellular areas. Rabbits immunized with
this ethanol soluble fraction produced anti-
bodies yielding immunofluorescent staining pat-
terns indistinguishable from those of "pemphi-
gus" antibodies (43, 44). First, these
appeared only as hetero antibodies (i.e., they re-
acted with only bovine epithelium) but upon
continued immunization, antibodies reactive
with rabbit epithelium appeared (48). At this
time some transient skin abnormalities also ap-
peared. The ethanol soluble fraction has also
yielded gel precipitation reactions not only with
these rabbit antisera but interestingly, with
some sera of Brazilian pemphigus foliaceus
(49). This new lead is currently under in-
vestigation.
vi. SUMMARY OF SALIENT OBSERVATIONS
AND THEIR IMPLICATION
A. Summary of Evidence on Autoimmune
Etiology of Fern phi gus and of
Bullous Fern phigoid
The present evidence for an autoimmune
etiology for true pernphigus, although mostly
circumstantial, may be summarized as follows:
1) the intercellular antibodies are autoanti-
bodies; 2) the histologic localization of these
intercellular antibodies of pemphigus cor-
responds to the site of the primary demon-
strable histopathologic change in the disease.
(This has been borne out by electron micro-
scopic studies 50—53.) 3) they appear to fix
complement in vivo (though apparently not n
vitro); 4) they have thus far, beer found only
in patients with pemphigus; 5) the severity of
lesions is proportional to the titer of the in-
tercellular antibodies; titers fluctuate with
changes in the patient's condition; 6) in at
least two cases (6, 29), the intercellular anti-
bodies were found before histologically char-
acteristic lesions appeared (typical pemphigus
lesions appeared shortly thereafter) ; 7) im-
munization of rabbits with insoluble or soluble
fractions of stratified squamous epitlielia have
yielded "pemphigus like" antibodies and some
evidence suggestive of experimental pemphigus.
The in vivo fixation of both TgG and coinple-
ment in the skin in pemphigus patients are
strongly suggestive of some pathologic ef-
fect of the autoantibodies in the intercellular
areas (19). Also, the experimental induction of
acantholvtic lesions in rabbits sensitized with
epithelial extracts is strongly suggestive (46).
However, these observations cannot be re-
garded as unequivocal proof of the etiologic
role of these autoantibodies in the pathogenesis
of pemphigus. To obtain this, it would be nec-
essary to transfer pemphigus passively with
pemphigus antibodies.
Cellular or delayed type hypersensitivity is
of doubtful relevance in pemphigus since pri-
mary lesions as a rule occur in the absetce of
inflammatory cells (1). Frequently the only
white cells seen near bullae are eosinophils.
The evidence for the autoimmune etiology of
bullous pemphigoid is also purely circum-
stantial. Tt is as follows: 1) the basenwnt
membrance antibodies are autoantibodies; 2)
the histologic localization of the basement
membrance antibodies correspond to the site of
the primary histopathologic changes in bullous
pemphigoid; 3) they appear to be fixed to the
basement membrane; 4) complement is con-
comitantly bound in vivo in the same region
(41) 5) basement membrane antibodies have
thus far been found only in bullous pemphi-
goid; 6) their presence in the circulation is
usually associated with active lesions. Tt is
obvious that less is known about tins bullous
pemphigoid system than about the pemphigus
system and that considerable work needs to
be done to elucidate the pathologic significance
of these basement membrane autoantibodies.
Obviously, further studies of experimental
model systems (45, 47) are needed for each of
these diseases.
B. Factors Operative in Eliciting
Fern phigus Antibodies
The available evidence suggests different
factors elicit "pemphigus" antibodies in differ-
ent forms of the disease. Epidemiologic evi-
dence suggests that an arthropod borne in-
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fectious agent incites antibody formation in
Brazilian pemphigus foliaceus (27) In contrast
pernpliigus er thematosus frequently occurs to—
gether with other immunologic disturbances,
notably with antinuclear antibodies and lupus
erytliematosus. As indicated, thyrnornas and
mvasthenia gravis may also concur with pern-
phigus. In these forms of the disease the forma-
tion of the pemphigus antibodies seems to be
incited by some immunologic disturbance (s)
The triggering factor in the most common
form of the disease, pemphigus vulgaris re-
mains an enigma at present. The only available
hint is that. the disease occurs preponderrrntly
among Jews and people of Mediterranean
origin. Blood group studies clearly indicate that
Jews are not a race. Since they do have a
distinct culture dietary factors may be opera-
tive. At tIns juncture such speculations are
pure science fiction.
C. Implications of Finding.
Pemphigus is characterized by its histo—
pathology; i.e., the acantholytic bullae (1, 55).
Now tins hallmark of the disease is supple-
mented by another: the intercellular antibodies.
The latter appear to be of equivalent diagnostic
reliability but have the advantage of affording
some quantitative measure of disease activity.
Thus, some clinicians familiar with the im—
mune response pattern use titers of inter-
cellular antibodies as a guide to the adjust-
ment of dosages of corticosteroids (29, 56).
Laryngeal pemphigus which poses special di-.
agnostic problems (57), has been successfully
characterized by immunofluorescence. Oral le-
sions which also are frequently difficult to
identify by their histopathology now may also
be identified immunologically. In some problem
cases, the demonstration of intercellular anti-
bodies has afforded the first clue of pemphi-
gus (7).
Bullous pempliigoid is frequently difficult to
distinguish from erythema multiforme or from
dermatitis herpetiformis on clinical or histo-
logical grounds (1). Immunofluorescence ob-
servations not only bear out the validity of the
distinction of bullous pemphigoid from other
dermatoses with subepidermal bullae but also
now provides a ready means of distinguishing
it (11) . It must be kept in mind that only
positive findings may be regarded as reliable;
some "false negatives" may be expected in tests
with patient sera. In the latter cases skin
biopsies may reveal in vivo binding of IgG
to the basement membrane.
Numerous problems relating to these two
types of autoantibodies remain to be resolved.
These include, the characterization of the anti-
gens with which they react, the cause of the
formation of the autoantibodies, the efficacy of
immunosuppressive drugs in treating these dis-
eases, the further studies of experimental ani-
mals, characterization of the purported vector
and agent of Brazilian pemphigus, studies on
the role of the thvmus and many others. Ob-
viously, further exploratory and experimental
studies of such areas are needed to afford a
better utderstanding of the nature of these dis-
eases and of methods of coping with them.
REFERENCES
1. Lever, W. F.: Pemphigus and Pemphigoid,
Springfield, Ill., Chas. C Thomas Co., 1965.
2. Beutner, K H. and Jordon, R. E.: Demon-
stration of skin antibndies in sera of pemphi-
gus vulgaris patients by indirect immuno—
fluorescent straining. Proc. Soc. Exptl. Biol.
& Med. 117: 505, 1964.
3. Beutner, E. H., Lever, IV. F., Witebsky, E.,
Jordon, R. E. and Chertock, B.: Autoanti-
bodies to pemphigus vulgaris. JAMA, 192:
682, 1965.
4. Waldorf, D. S., Smith, C. W. and Strauss, A. J.
L.: Immunofluorescent studies in pemphigus
vulgaris. Arch. Derm., 93: 28, 1966.
5. Chorzelski, T. P., von Weiss, J. and Lever, W.
F.: Clinical significance of autoantibodies in
pemphigus. Arch. Derm., 93: 570, 1966.
6. Chorzelski, T. P., Jablonska, S. and Blaszcyk,
M.: Autoantibodies in pemphigus. Acta Der-
mato-venerol. Sven Hellerstrorn 65 yrs., 26,
1966.
7. Beutner, E. H., Chorzelski, T. P., Hale, W. L.
and Petrusewicz, H.: Autoimmunity in a
case with concurrent myasthenia gravis and
pemphigus erythematosus. JAMA, 203: 10,
1968.
8. Beutner, E. H., Prigenzi, L. S., Hale W., Leme,
C. A. and Bier, 0.: Immunofluorescent stud-
ies of autoantihodies to intercellular areas of
epithelia in Brazilian pemphigus foliaceus.
Proc. Soc. Exptl. Biol. & Med., 127: 81, 1968.
9. Chorzelski, T., Jablonska, S. and Blaszczyk,
M.: Immunopathologisehe untersuchungen
bei der subeornealen pustulosen Dermatose
Sneddon-Wilkinson. thorn. It.al Derm., 107:
809, 1966.
10. Beutner, E. H., Rhodes, E. L. and Holborow
E. J.: Autoimrnunitv in chronic hullous skin
diseases. Clin. Exptl. Immunol., 2: 141, 1961.
11. Jordon, R. E., Beutner, E. H., Witebsky, E.,
Blumental, G., Hale, W. L. and Lever, W. F.:
Basement zone antibodies in bullous pern-
phigoid. JAMA, 200: 751, 1967.
12. Chorzelski, T., Jablonska, S., Blaszczyk, M
and Jarzahek, M.: Autoantibodies in pemphi-
goid. Dermatologica. In press.
IMMITNOPATHOLOGY OF PEMPHIGIJS 79
13. Wagner, V., Seba, G. and Hruskova, B.: Dem-
onstration of tissue autoantibodies in the
blood serum of patients with certain skin
diseases. Dermatologica, 112: 25, 1956.
14. Melczer, N. and Vasarhelyi, P.: Specific hem-
agglutinins in serum and spinal fluid of pa-
tients with pemphigus and dermatitis herpet-
iformis. Acta Dermato-vener., 38: 198, 1958.
15. Kano, K., Beutner, E. H. and Milgrom, F.:
Hurnoral antibodies in sera of patients with
bullous skin diseases. Proc. Soc. Exptl. Biol.
& Med., 127: 355, 1968.
16. Beutner, E. H., Holobrow, E. J. and Johnson,
G. D.: Quantitative studies of immunofluore-
scent staining. I. Analyses of mixed immuno-
fluorescence. Immunol., 12: 327, 1967.
17. Beutner, E. H, Sepulveda, M. and Barnett, E.:Quantitative studies of immunofluorescence.
III. Characterization of unabsorbed antihu-
man IgG conjugates. Bull. WHO. In press.
18. Chertock, B. L.: Skin testing of animals with
sera from patients with pemphigus vulgaris
using immunofluorescent techniqiues. Honors
Thesis, SUN at Buffalo, School of Medicine,
1967.
19. Cormane, R. H. and Chorzelski, T. P.: "Bound"
complement in tile epidermis of patients with
pemphigus vulgaris. Dermatologica, 134:
463, 1967.
20. Stringa, et at. In preparation for Inter. Con.
Derm., 1967.
21. Prigenzi, L. S., Beutner, E. H. and Bier, 0.: In
preparation.
22. Bier, 0. et al. In preparation.
23. Burnham, T. K., Nehlett, T. H. and Fine, G.:
The application of the fluorescent antibody
technique to the investigation of lupus cry—
thematosus and various dermatoses. J. In-
vest. Derm., 41: 451, 1963.
24. Cormane, R. H.: Bound globulin in skin of pa-
tients with cbronic discois L. E. and S. L. E.
Lancet, 1: 534, 1964.
25. Tan, E. M. and Kunkel, H. G.: An immuno-
fluorescent study of skin lesions in systemic
lupus erythematosus. Arth. Hheurn., 9: 37,
1966.
26. Leme, C. A.: Personal Communication.
27. Lerne, C. A.: Penfigo foliaceo—etiopatogenia,
sintomatologia e diagnostico 0 Hospital, 65:
1081, 1964.
28. Castro, 0.: Aspectos epidermiologicos e clini-
cos do Penfigo foliaceus em minas gerais.
Tese. Imprensa Oficial, Belo Horizonte, 1945.
29. Peck, S. M., Osserman, K. E., Lefkovits, A., and
Osserman, H. S. Studies in bullous diseases:
Immunofluoreseent serologic tests. Submitted
to N. E. J. Med.
30. Strauss, A. J. L., van der Geld, H. W. R.,
Kemp, P. G., Jr., Exurn, E. D. and Goodman,
H. C.: Immunologic concomitants of myas-
thenia gravis. Ann. N. Y. Acad. Sci., 124:
744, 1965. (Note: the patient with con-
comitant pemphigus was included with "dis-
ease controls" but is not listed in the publica-
tion.)31. Rough, R. H. and Barnes, W. T.: Thymoma
associated with erythroid plasia bullous skin
eruption and the lupus !erythematosus cell
phenomenon. Ann Inter. Med., 61: 308, 1964.
32. Cram, D. L. and Winkelmann, R. K.: Ultra-
violet induced acantholysis in pemphigus.
Arch. Derm., 92: 7, 1965.
33. Chorzelski, T. P., Jablonska, S., and Blaszczyk,
M.: Immunopatbologic investigation in the
Senear-lJsher Syndrome. Coexistence of
pemp}iigus with J.upus erythematosus. Brit. J.
Derm. In press.
34. Senear, F. E. and Usher, B.: An unusual type
of pemphigus combining features of lupus
erythernatosus. Arch. Derm. Syph., 1: 761,
1926.
35. Jablonska, S.: Le syndrome de Senear Usher.
Acta Derruato-vener., 29: 361, 1949.
36. Jordon R. E., Muller, S. A., Hale, W. L. and
Beutner, E. H.: Bullous pempbigoid asso-
ciated with systemic lupus erythematosus.
In preparation.
37. Triftshauser, C. T., Jordon, H. E., Hale, W.
Sams, W. M., Jr. and Beutner E. H.: Immun-
ofluorescent studies of basement membrane,
autoantibodies in the sera and blister fluid
from patisnts with hullous pempbigoid. In
preparation.38. Szulrnan, A. E.: The histological distribution
of blood group substances A and B in man,
J. Exptl. Med., 111: 785, 1960.
39. Grob, P. J. and Inderbitzen, rf M.: Pemphigus
antigen and blood group substances A and
B. J. Invest. Derm., 49: 285, 1967.
40. Barnard E. A., Osyrowski, K., Chorzelski, T. P.,
Milulski, A., Langner, A., and Sawicki, W. In
preparation.
41. Chorzelski, T. P., Biczyski, W., IDabrowski, J.
and Jarzabek, M.: llJltrastructural localiza-
tion of "pemphigus" autoantibodies. J. In-
vest. Dorm., 50: 36, 1968.
42. Chorzelski, T. P. and Cormane, R. H.: The pre-
sence of complement bound in vivo in the
skin of patients with pemphigoid. Derma-
tologica. In press.
43. Beutner, E. H. and Ablm, R. J.: Precipitation
reactions with epithelial antigens and "pern-
higus" heteroantibodies of rabbit and human
pemphigus autoantihodies. Fed. Proc., 1968.
44. Ablin, R. J. and Beutner, E. H.: Antigens of
esophageal mucosa reactive antibodies of
pemphigus. I.A.D.R., 1968.
45. Grob, P. J. and Inderhitzen, T. M.: Experimen-
tal production in rabbits of antiepithelial
autoantibodies. J. Invest. Derm., 49: 637,
1967.
46. Inderhitzen, T. M. and Grob, P. J.: Destruc-
tion of epithelial cells in vivo by antiepithe—
hal autoantibodies. J. Invest. Derm., 49: 642,
1967.
47. Ablin, R. J. and Beutner, E. H.: Absorption
studies on antigen(s) of the esophageal mu-
cosa reactive with autoantihodies of pempbi-
gus. Inter. Arch. Allergy & Appl'd Immunol.,
33: 227, 1958.
48. Witebsky, E., Ahlin, H. J. and Beutner, F. H.:
Production f "pemphigus" like hetero-, iso—
aid autoantibodies. In preparation.
49. Ablin, H. J., Bronson, P. and Beutner, E. H.:
Immunochemical characterization of antigen
(s) reactive with "pempbigus" like hetero—,
iso-, and autoantibodies. In preparation.
50. Thivolet, J., Beyvin, A. J. Hecherche par irn-
munofluorescence d'auto anticorps seriques
ViS a vis des constituants de l'epiderme chez
les brules. Experiencia. In press.
51. Braun-Falco, 0. and Vogell, W.: Elektronen-
mikroskopische Tlntersuchungen zur Dyna-
mik der Akantholyse bei Pemphigus vulgaris
I. Die Iclinisch normal assenende Hant in
80 THE JOURNAL OF INVESTIGATIVE DEI1MATOLOY
der Umgebung von B]asen mit positivem
Nikoiski-Phenomen. Arch. Kim. Exp. Derm.,
3: 328, 1965,
52. Braun-Falco, 0. and Vogel!, W.: Elektronen-
rnikroskipische Untersuchungen zur Dyna-
mik der Akanthoiyse bei Pemphigus vul-
garis. II. Mitteiiung, Die akanthoiytmsche
Blase. Arch, Klin, Exp. Derm., 933: 533,
1965.
53. Hashimoto, K. and Lever, W. F. The inter-
celiuiar cement in pemphigus vulgaris, and
electron microscopic study. Derrnatologmca,
135: 27, 1967.
54. Hashimoto, K. and Lever, W. F. An electron
mieroscopmc study on pemphmgus vuigaris of
the mouth and the skin with special reference
to the interceiiuiar cement. J. Invest. Derm.,
48: 540, 1967,
55. Civatte, A.: Diagnostic histopathologique de
ia dermatite polyrnorphe douloureuse ou ma!-
adie de Duhring-Brocq. Ann. Derm. et Syph.,
3: 1, 1943.
56. Chorzelski, T., Jabionska, S. and Blaszczyk,
M.: Wart de Autoantikorperbestiinrnung in
pemphigus. Hautarzt, 18: 521, 1967.
57. Waiiner. L, J. and Aiexander, It. W.: Pemphi-
gus of the larynx. Laryngoscope LXXIV:
575, 1964.
58. Wick, G. and Beutner, E. H.: Quantitative
studies of immunofluorescent staining. III.
Submitted for pubiication.
